Immunotherapy for childhood warts

Pediatric Annals

Volumn 38, Issue 7, 2009, Pages 373-379

  Dasher, David A ^a   Burkhart, Craig N ^a   Morrell, Dean S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; BLEOMYCIN; CANDIDA ANTIGEN; CIMETIDINE; DIPHENCYPRONE; FLUOROURACIL; IMIQUIMOD; LIQUID NITROGEN; SALICYLIC ACID; SQUARIC ACID DIBUTYL ESTER; STEROID; AMINOQUINOLINE DERIVATIVE; ANTIGEN; CYCLOBUTANE DERIVATIVE; CYCLOPROPANE DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOLOGICAL ADJUVANT; IRRITANT AGENT;

APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE PIGMENTATION CHANGE; APPLICATION SITE PRURITUS; BLISTER; BREAST TENDERNESS; CHILDHOOD DISEASE; CONTACT DERMATITIS; CONTACT SENSITIZATION; CRYOTHERAPY; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; EXCISION; GYNECOMASTIA; HUMAN; HYPERSENSITIVITY REACTION; IMMUNOTHERAPY; LASER SURGERY; LYMPHADENOPATHY; NAUSEA; NONHUMAN; OBSERVATION; PAIN; PRURITUS; REVIEW; SCAR FORMATION; SKIN BURNING SENSATION; TREATMENT DURATION; TREATMENT OUTCOME; URTICARIA; VERRUCA VULGARIS; CHILD; INTRALESIONAL DRUG ADMINISTRATION; METHODOLOGY; PRESCHOOL CHILD;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; ANTIGENS; CHILD; CHILD, PRESCHOOL; CIMETIDINE; CYCLOBUTANES; CYCLOPROPANES; DINITROCHLOROBENZENE; HISTAMINE H2 ANTAGONISTS; HUMANS; IMMUNOTHERAPY; INJECTIONS, INTRALESIONAL; IRRITANTS; TREATMENT OUTCOME; WARTS;

EID: 70149106790     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20090622-06     Document Type: Review

References (39)

1. Stern R, Johnson M, DeLozier J. Utilization of physician services for dermatologic complaints. Arch Dermatol. 1977;113(8):1062-1066.
2. Cobb MW. Human papillomavirus infection. J Am Acad Dermatol. 1990;22(4):547-566.
3. Massing AM, Epstein WL. Natural history of warts. Arch Dermatol 1963;87:306-310.
4. Tagami H, Ogino A, Takigawa M, et al. Regression of plane warts following spontaneous inflammation. Br J Dermatol. 1974;90(2):147-154.
5. Berman A, Winkelmann RK. Involuting common warts. Clinical and histopathologic findings. J Am Acad Dermatol. 1980;3(4):356-362. (Pubitemid 11219511)
6. Frazier I. Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology. 2009;20;384(2):410-414
7. Harper DM, Franco EL, Wheeler CM, et al; HPV Vaccine Study group. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):1247-1255.
8. Villa LL, Costa RL, Petta CA, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer. 2006;95(11):1459- 1466.
9. Jin Z, Kumar A, Cleveland RP, et al. Inhibition of suppressor cell function by cimetidine in a murine model. Clin Immunol Immunopathol. 1986;38(3):350-356. (Pubitemid 16117971)
10. Jorizzo JL, Sams WM Jr, Jegasothy BV, et al. Cimetidine in chronic cutaneous candidiasis. Arch Dermatol 1979;115(10):1171.
11. White WB, Ballow M. Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia. N Engl J Med. 1985;312(4):198-202. (Pubitemid 15115152)
12. Simon GL, Miller HG, Scott SJ. Cimetidine in the treatment of hyperimmunoglobulinemia E in impaired chemotaxis. J Infect Dis 1983;147(6):1121-1122
13. Cohen PR, Kurzrock R. Herpes simplex virus infections and cimetidine therapy. J Am Acad Dermatol. 1988;19:762-763.
14. Orlow SJ, Paller A. Cimetidine therapy for multiple viral warts in children. J Am Acad Dermatol. J Am Acad Dermatol. 1993;28(5 Pt 1):794-1766 (Pubitemid 23133400)
15. Fischer G, Rogers M. Cimetidine therapy for warts in children. J Am Acad Dermatol. 1997;37(2 Pt 1):289-290.
16. Glass AT, Soloman BA. Cimetidine therapy for recalcitrant warts in adults. Arch Dermatol. 1996;132(6):680-682. (Pubitemid 26174109)
17. Yilmaz E, Alpsoy E, Basaran E. Cimetidine therapy for warts: a placebo-controlled, double-blind study. J Am Acad Dermatol. 1996;34(6):1005- 1007. (Pubitemid 26170766)
18. Karabulut AA, Sahin S, Eksioglu M. Is cimetidine effective for nongenital warts: a double-blind placebo-controlled study. Arch Dermatol. 1997;133(4):533-534. (Pubitemid 27175713)
19. Rogers CJ, Gibney MD, Siegfried EC, et al. Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo? J Am Acad Dermatol. 1999;41(1):123-127.
20. Bauman C, Francis JS, Vanderhooft S, et al. Cimetidine therapy for multiple viral warts in children. J Am Acad Dermatol. 1996;35(2):271-272. (Pubitemid 26260262)
21. Saenz-Santamarie MC, Gilaberte Y. Cimetidine and warts. Arch Dermatol. 1997;133(4):530-531.
22. Gibbs S, Harvey I. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2006;3:CD001781.
23. Torrelo A. What's new in the treatment of viral warts in children. Pediatric Dermatol. 2002;19(3):131-134. (Pubitemid 34625776)
24. Buckley DA, Keane FM, Munn SE, et al. Recalcitrant viral warts treated by diphencyprone immunotherapy. Br J Dermatol. 1999;141(2):292-296.
25. Rampen FH, Steijlen PM. Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study. Dermatology. 1996;193(3):236-238.
26. Orecchia G, Douville H, Santagostino L, et al. Treatment of multiple relapsing warts with diphenciprone. Dermatologica. 1988;177(4):225-231.
27. Naylor MF, Neldner KH, Yarbrough GK, et al. Contact immunotherapy of resistant warts. J Am Acad Dermatol. 1988;19(4):679-683
28. Iijima S, Otsuka F. Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester. Arch Dermatol. 1997;133(4):539-540. (Pubitemid 27175718)
29. Silverberg NB, Lim JK, Paller AS, Mancini AJ. Squaric acid immunotherapy for warts in children. J Am Acad Dermatol. 2000;42(5 Pt 1):803-808.
30. Micali G, Nasca MR, Tedeschi A, Dall'Oglio F, Pulvirenti N. Use of squaric acid dibutylester (SADBE) for cutaneous warts in children. Pediatr Dermatol. 2000;17(4):315-318. (Pubitemid 30212978)
31. Johnson SM, Roberson PK, Horn TD. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol. 2001;137(4):451-455.
32. Clifton MM, Johnson SM, Roberson PK, et al. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens. Pediatr Dermatol. 2003;20(3):268-271.
33. Maronn M, Salm C, Lyon V, Galbraith S. One-year experience with candida antigen immunotherapy for warts and molluscum. Pediatr Dermatol. 2008;25(2):189-192. (Pubitemid 351579600)
34. Perman M, Sterling JB, Gaspari A. The painful purple digit: an alarming complication of Candida albicans antigen treatment of recalcitrant warts. Dermatitis. 2005;16(1):38-40. (Pubitemid 40667530)
35. Schön MP, Schön M. Imiquimod: mode of action. Br J Dermatol. 2007;157 Suppl 2:8-13.
36. Hengge UR, Esser S, Schultewolter T, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol .2000;143(5):1026-1031.
37. Grussendorf-Conen EI, Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol. 2002;19(3):263-326 (Pubitemid 34625790)
38. Harwood CA, Perrett CM, Brown VL, et al. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals. Br J Dermatol. 2005;152(1):122-129. (Pubitemid 40193844)
39. Housman TS, Jorizzo JL. Anecdotal reports of 3 cases illustrating a spectrum of resistant common warts treated with cryotherapy followed by topical imiquimod and salicylic acid. J Am Acad Dermatol. 2002;47(4 Suppl): S217-S220.